PLOS
open access
CC BY 4.0
Integrative methylome and transcriptome analyses identify <i>LHX3</i> as an epigenetically downregulated marker with tumor suppressive properties in breast cancer
Breast cancer (BC) remains a major global health concern, with rising incidence and mortality rates. Early diagnosis of BC plays an important role in its prevention. However, number of clinically validated biomarkers that enable accurate and minimally invasive diagnosis are still insufficient. Epig
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Comprehensive bioinformatics analysis identifies DNA methylation signatures associated with immune evasion and predicts immunotherapy response in breast cancer.#368180
- Choose to Lose for Women-Weight Loss to Reduce Breast Cancer Risk Factors#162373
- Race, ethnicity, and experienced racism are associated with adverse physical and mental health outcomes among cancer survivors.#685779
- From Mechanisms to Manifestations: A Scoping Review Exploring Cancer-Related Discrimination.#1134854
- Epidemiology Controls Using Healthy Participants#1185100
Record · ID 1237181
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive